Back to Search
DR. ALLISON T. HANNAN M.D.
M.D.
Family Medicine Physician
NPI: 1093152209IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD457588(PA)
Education
TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
International Brain Research Organization--Seventh World Congress of Neuroscience. 12-17 July 2007, Melbourne, Victoria, Australia.
PMID 17899483·IDrugs·2007
7-preclinical
Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.
PMID 16716524·Neuroscience·2006
4-observational
Novel therapeutic targets for Huntington's disease.
PMID 16083335·Expert Opin Ther Targets·2005
6-review
Australian Neuroscience Society--25th Annual Meeting. 30 January-2 February 2005, Perth, Australia.
PMID 15772885·IDrugs·2005
7-preclinical
Australian Neuroscience Society--24th annual meeting. 27-30 January 2004, Melbourne, Australia.
PMID 15017454·IDrugs·2004
7-preclinical
International Brain Research Organization--Sixth World Congress of Neuroscience. 10-15 July 2003, Prague, Czech Republic.
PMID 14565171·IDrugs·2003
7-preclinical
British Neuroscience Association - 16th National Meeting. 8-11 April 2001, Harrogate, UK.
PMID 15995931·IDrugs·2001
8-other
PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex.
PMID 11224545·Nat Neurosci·2001
7-preclinical
Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
PMID 19499586·Hippocampus·2010
7-preclinical
Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
PMID 19454847·Am J Geriatr Psychiatry·2009
7-preclinical
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
PMID 19524019·Neuroscience·2009
7-preclinical
Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
PMID 19236734·Int J Neuropsychopharmacol·2009
7-preclinical
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
PMID 18593507·Int J Neuropsychopharmacol·2009
7-preclinical
Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
PMID 19008301·Hum Mol Genet·2009
7-preclinical
Hospital management of severely malnourished children: comparison of locally adapted protocol with WHO protocol.
PMID 19179742·Indian Pediatr·2009
4-observational
Towards a therapy for Huntington's disease (Commentary on Giampà et al.).
PMID 19291220·Eur J Neurosci·2009
7-preclinical
Risk factors for infection with highly pathogenic influenza A virus (H5N1) in commercial chickens in Bangladesh.
PMID 19525522·Vet Rec·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 555 N DUKE ST
LANCASTER, PA 17602 - Phone
- (717) 544-7228
Quick Facts
- NPI
- 1093152209
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile